Alpha-1 Antitrypsin Drugs Global Strategic Research Report 2024: Advances in Biomarker Identification Generate New Opportunities for Targeted Therapies - Forecast to 2030
September 20, 2024 09:24 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Alpha-1 Antitrypsin Deficiency Market and Epidemiology Forecast to 2032
May 21, 2024 04:02 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offeringA...
Alpha-1 Antitrypsin Deficiency Epidemiology Insights and Forecasts, 2019-2022 & 2023-2032: Focus on United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan
April 30, 2024 04:22 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This 'Alpha-1 Antitrypsin...
Alpha-1 Antitrypsin Deficiency (AATD) Epidemiology Forecast to 2032 Across the 7MM
January 29, 2024 12:07 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This research offers a...